BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18446005)

  • 1. Intact cell binding for in vitro prediction of sedative and non-sedative histamine H1-receptor antagonists based on receptor internalization.
    Hishinuma S; Sato Y; Kobayashi Y; Komazaki H; Saito M
    J Pharmacol Sci; 2008 May; 107(1):66-79. PubMed ID: 18446005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the binding of [3H]-mepyramine to intact human U373 MG astrocytoma cells: evidence for histamine-induced H1-receptor internalisation.
    Hishinuma S; Young JM
    Br J Pharmacol; 1995 Nov; 116(6):2715-23. PubMed ID: 8590995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants responsible for sedative and non-sedative properties of histamine H₁-receptor antagonists.
    Uesawa Y; Hishinuma S; Shoji M
    J Pharmacol Sci; 2014; 124(2):160-8. PubMed ID: 24476926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The affinity of histamine for Gq protein-coupled histamine H(1)-receptors is predominantly regulated by their internalization in human astrocytoma cells.
    Hishinuma S; Sato Y; Akatsu C; Shoji M
    J Pharmacol Sci; 2012; 119(3):233-42. PubMed ID: 22786583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative prediction of histamine H1 receptor occupancy by the sedative and non-sedative antagonists in the human central nervous system based on systemic exposure and preclinical data.
    Kanamitsu K; Nozaki Y; Nagaya Y; Sugiyama Y; Kusuhara H
    Drug Metab Pharmacokinet; 2017 Apr; 32(2):135-144. PubMed ID: 28190755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca2+/calmodulin-mediated regulation of agonist-induced sequestration of Gq protein-coupled histamine H1 receptors in human U373 MG astrocytoma cells.
    Hishinuma S; Naiki A; Tsuga H; Young JM
    J Neurochem; 1998 Dec; 71(6):2626-33. PubMed ID: 9832164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clathrin-independent internalization of the human histamine H1-receptor in CHO-K1 cells.
    Self TJ; Oakley SM; Hill SJ
    Br J Pharmacol; 2005 Oct; 146(4):612-24. PubMed ID: 16086035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal of human histamine H
    Hishinuma S; Nozawa H; Akatsu C; Shoji M
    J Neurochem; 2016 Nov; 139(4):552-565. PubMed ID: 27566099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.
    Bosma R; Moritani R; Leurs R; Vischer HF
    Pharmacol Res; 2016 Sep; 111():679-687. PubMed ID: 27468652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in pH differently affect the binding properties of histamine H1 receptor antagonists.
    Gillard M; Chatelain P
    Eur J Pharmacol; 2006 Jan; 530(3):205-14. PubMed ID: 16388798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between histamine H1 receptor and its antagonists by using cell membrane chromatography method.
    Ma W; Zhang D; Li J; Che D; Liu R; Zhang J; Zhang Y
    J Pharm Pharmacol; 2015 Nov; 67(11):1567-74. PubMed ID: 26147217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin/proteasome-dependent down-regulation following clathrin-mediated internalization of histamine H1-receptors in Chinese hamster ovary cells.
    Hishinuma S; Komazaki H; Fukui H; Shoji M
    J Neurochem; 2010 May; 113(4):990-1001. PubMed ID: 20236220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine H1 receptors on adherent rheumatoid synovial cells in culture: demonstration by radioligand binding and inhibition of histamine-stimulated prostaglandin E production by histamine H1 antagonists.
    Taylor DJ; Woolley DE
    Ann Rheum Dis; 1987 Jun; 46(6):425-30. PubMed ID: 2888437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of Lys191 and Lys179 in regulating thermodynamic binding forces of ligands to determine their binding affinity for human histamine H
    Kobayashi C; Tanaka A; Yasuda T; Hishinuma S
    Biochem Pharmacol; 2020 Oct; 180():114185. PubMed ID: 32738199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-based, animal and H
    Feng F; Fawcett JP; Zhang H; Tucker IG
    J Pharm Pharmacol; 2020 Apr; 72(4):507-518. PubMed ID: 32030755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by cations of antagonist binding to histamine H1-receptors.
    Treherne JM; Stern JS; Flack WJ; Young JM
    Agents Actions Suppl; 1991; 33():271-6. PubMed ID: 1675834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors? An in vitro study.
    Ter Laak AM; Donné-Op den Kelder GM; Bast A; Timmerman H
    Eur J Pharmacol; 1993 Mar; 232(2-3):199-205. PubMed ID: 8096817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity, saturable [3H]mepyramine binding sites on rat liver plasma membrane do not represent histamine H1-receptors. A warning.
    Leurs R; Bast A; Timmerman H
    Biochem Pharmacol; 1989 Jul; 38(13):2175-80. PubMed ID: 2567596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies.
    Sharif NA; Su SX; Yanni JM
    J Ocul Pharmacol; 1994; 10(4):653-64. PubMed ID: 7714409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.